[go: up one dir, main page]

DK204388A - Substituerede piperidiner til anvendelse som opioidantagonister og fremgangsmaade til fremstilling af saadenne forbindelser - Google Patents

Substituerede piperidiner til anvendelse som opioidantagonister og fremgangsmaade til fremstilling af saadenne forbindelser

Info

Publication number
DK204388A
DK204388A DK204388A DK204388A DK204388A DK 204388 A DK204388 A DK 204388A DK 204388 A DK204388 A DK 204388A DK 204388 A DK204388 A DK 204388A DK 204388 A DK204388 A DK 204388A
Authority
DK
Denmark
Prior art keywords
procedures
compounds
making
opioid antagonists
substituted piperidines
Prior art date
Application number
DK204388A
Other languages
English (en)
Other versions
DK204388D0 (da
Inventor
Charles Howard Mitch
Dennis Michael Zimmerman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK204388D0 publication Critical patent/DK204388D0/da
Publication of DK204388A publication Critical patent/DK204388A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK204388A 1987-04-16 1988-04-14 Substituerede piperidiner til anvendelse som opioidantagonister og fremgangsmaade til fremstilling af saadenne forbindelser DK204388A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3912187A 1987-04-16 1987-04-16

Publications (2)

Publication Number Publication Date
DK204388D0 DK204388D0 (da) 1988-04-14
DK204388A true DK204388A (da) 1989-01-05

Family

ID=21903800

Family Applications (1)

Application Number Title Priority Date Filing Date
DK204388A DK204388A (da) 1987-04-16 1988-04-14 Substituerede piperidiner til anvendelse som opioidantagonister og fremgangsmaade til fremstilling af saadenne forbindelser

Country Status (21)

Country Link
EP (1) EP0287339B1 (da)
JP (1) JP2661699B2 (da)
KR (1) KR960015087B1 (da)
CN (1) CN1017992B (da)
AR (1) AR245933A1 (da)
AT (1) ATE110057T1 (da)
AU (1) AU596290B2 (da)
CA (1) CA1321792C (da)
DE (1) DE3851081T2 (da)
DK (1) DK204388A (da)
EG (1) EG18864A (da)
ES (1) ES2058265T3 (da)
HU (1) HU202492B (da)
IE (1) IE64508B1 (da)
IL (1) IL86061A (da)
MX (1) MX11117A (da)
NZ (1) NZ224236A (da)
PH (1) PH24752A (da)
PT (1) PT87233B (da)
SU (1) SU1598869A3 (da)
ZA (1) ZA882640B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0299549A3 (en) * 1987-07-09 1989-02-08 Duphar International Research B.V Tertiary 2,5-dialkyl-3-phenyl-piperidine derivatives having opiate-antagonistic activity
ZA922180B (en) * 1991-03-29 1993-09-27 Lilly Co Eli Piperidine derivatives
GB9202238D0 (en) * 1992-02-03 1992-03-18 Wellcome Found Compounds
US5681830A (en) * 1992-02-03 1997-10-28 Delta Pharmaceuticals, Inc. Opioid compounds
US5574159A (en) * 1992-02-03 1996-11-12 Delta Pharmaceuticals, Inc. Opioid compounds and methods for making therefor
US5807858A (en) * 1996-06-05 1998-09-15 Delta Pharmaceutical, Inc. Compositions and methods for reducing respiratory depression
US5985880A (en) * 1996-06-05 1999-11-16 Delta Pharmaceuticals Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
IL110512A (en) * 1993-07-30 1998-10-30 Delta Pharmaceuticals Inc History of diarylmethyl piperazine, their preparation and pharmaceutical preparations containing them
GB9725114D0 (en) * 1997-11-28 1998-01-28 Pfizer Ltd Treatment of pruritus
GB9810671D0 (en) * 1998-05-18 1998-07-15 Pfizer Ltd Anti-pruritic agents
GB9815618D0 (en) 1998-07-18 1998-09-16 Univ Manchester Treatment of dyskinesia
TWI244481B (en) 1998-12-23 2005-12-01 Pfizer 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
GB9912410D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912415D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912416D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912413D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912411D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912417D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
JP2003528819A (ja) * 1999-11-29 2003-09-30 アドラー コーポレーション オピオイドおよびそのアンタゴニストに関する新規方法および組成物
GB0015562D0 (en) * 2000-06-23 2000-08-16 Pfizer Ltd Heterocycles
OA12711A (en) 2001-10-22 2006-06-27 Pfizer Prod Inc 3-AzabicycloÄ3.1.0Ühexane derivatives as opoioid receptor antagonists.
DE60321207D1 (en) * 2002-09-19 2008-07-03 Lilly Co Eli Diaryläther als opioid-rezeptor antagonisten
US7538110B2 (en) 2005-10-27 2009-05-26 Adolor Corporation Opioid antagonists
CN103917096A (zh) * 2011-07-18 2014-07-09 阿得罗公司 外周阿片样物质拮抗剂化合物的制备方法及所述化合物的中间体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR206937A1 (es) * 1974-09-06 1976-08-31 Lilly Co Eli Procedimiento para preparar compuestos de 1-sustituido-4-alquil-4-fenil-piperidina

Also Published As

Publication number Publication date
MX11117A (es) 1993-11-01
EP0287339A2 (en) 1988-10-19
CN88102191A (zh) 1988-11-02
IL86061A (en) 1992-07-15
DK204388D0 (da) 1988-04-14
EP0287339B1 (en) 1994-08-17
ZA882640B (en) 1989-12-27
IE64508B1 (en) 1995-08-09
JPS63277661A (ja) 1988-11-15
IL86061A0 (en) 1988-09-30
JP2661699B2 (ja) 1997-10-08
AU1462488A (en) 1988-10-20
NZ224236A (en) 1990-08-28
DE3851081D1 (de) 1994-09-22
KR880012551A (ko) 1988-11-28
PT87233A (pt) 1988-05-01
EP0287339A3 (en) 1991-05-15
SU1598869A3 (ru) 1990-10-07
HUT46892A (en) 1988-12-28
ES2058265T3 (es) 1994-11-01
CN1017992B (zh) 1992-08-26
PT87233B (pt) 1992-07-31
IE881125L (en) 1988-10-16
DE3851081T2 (de) 1995-02-16
EG18864A (en) 1995-06-29
ATE110057T1 (de) 1994-09-15
AR245933A1 (es) 1994-03-30
CA1321792C (en) 1993-08-31
KR960015087B1 (ko) 1996-10-24
HU202492B (en) 1991-03-28
AU596290B2 (en) 1990-04-26
PH24752A (en) 1990-10-01

Similar Documents

Publication Publication Date Title
DK204388A (da) Substituerede piperidiner til anvendelse som opioidantagonister og fremgangsmaade til fremstilling af saadenne forbindelser
KR880017788U (ko) 자기진단용 다기능 테스터
NO914429L (no) Fremgangsmaate for fremstilling av piperidinylkamfersulfonyloxytocin-antagonister
DK674288A (da) Fremgangsmaade til fremstilling af mikrokapsler
KR960700722A (ko) 피브리노겐 수용체 길항제(Fibrinogen receptor antagonists)
DK530888A (da) Leukotrien -ltd4- og - ltb4-antagonister
DK475286D0 (da) N-substituerede piperidiner
DK74680A (da) Fremgangsmaade til fremstilling af histaminantagonister
FI943933L (fi) Menetelmä fibrinogeenireseptoriantagonistien valmistamiseksi
NO871809L (no) Smoeremidler og nye polyfluorerte forbindelser til bruk som additiver
DK161788D0 (da) Fremgangsmaade til fremstilling af zidovudin
DK656388D0 (da) Fremgangsmaade til iodering af en aromatisk forbindelse
DK156088D0 (da) Vaesketabsnedsaettende additiver til borehulscementeringsmaterialer
DK570688A (da) Fremgangsmaade til rensning af polyorganphosphanzenelastromerer
DK505888D0 (da) Fremgangsmaade til fremstilling af makrolidforbindelser
DK504988A (da) Fremgangsmaade til fremstilling af makrolidforbindelser
DK27988A (da) Fremgangsmaade til fremstilling af substituerede benzaldehyder
KR880021971U (ko) 건축용 칸막이의 수평조절 장치
FI903111A7 (fi) Bis(bentsyylipyrrolidiini)johdannaisia dopamiiniantagonisteina
DK115088D0 (da) Indretning til sammensoemning af konstruktionsdele
DK356288A (da) Fremgangsmaade til fremstilling af n-((4-hydroxy-pyrrolidin-2-on-1-yl)-acetyl)-glycinamid
DK504888D0 (da) Fremgangsmaade til fremstilling af makrolidforbindelser
ES544321A0 (es) Un nuevo procedimiento de preparacion de piperidinas susti- tuidas
DK347589A (da) Fremgangsmaade til fremstilling af quinolonforbindelser
ES549788A0 (es) Procedimiento de preparacion de derivados de 4-(bis(4-fluo- rofenil)metilen)-piperidina

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment